Anti-Asian Racism Escalates During COVID-19
The pandemic has led to a sudden rise in discrimination against people of Asian descent.
University of California San Francisco
Give to UCSFThe pandemic has led to a sudden rise in discrimination against people of Asian descent.
How I learned to use social media to advance the public’s understanding of COVID-19.
As the United States’ testing regime floundered early in the pandemic, scientists at UCSF and the Chan Zuckerberg Biohub created from scratch a diagnostic lab that became a model for the nation.
UCSF researchers are taking a closer look at COVID-19’s dizzying array of symptoms to get at the disease’s root causes.
A look at past outbreaks offers guidance on bringing the current one to an end – and on thwarting the next one.
How will the gene-editing tool CRISPR change our relationship with nature? Will it affect human evolution? This documentary explores these questions through interviews with the pioneering scientists who discovered CRISPR, the families whose lives are altered by this new technology, and the bioengineers who are testing it. UCSF alumna Sarah Goodwin, who earned her PhD in cell biology, is the leading science adviser on the film, as well as a producer.
Scientists at UCSF are exploring how we can improve our bodies – now and in the future – with science that sounds like sci-fi.
Basic scientist Zena Werb, who has studied cancer cells in UCSF labs for more than four decades, shares her take on the future of cancer medicine.
With the global population of seniors projected to reach 1.5 billion by 2050, it will be more important than ever to reduce the burden of age-related disease. In the future, science will allow us to intervene in the aging process to make this a reality, according to geriatrician John Newman.
Scientists have documented the influence of information overload on attention, perception, memory, decision-making, and emotional regulation. But the same technologies contributing to the cognition crisis could help solve it, argues neuroscientist Adam Gazzaley.
Advances in medicine and public health have dramatically extended the lifespan of hearts, lungs, and other vital organs. But for women, the ovaries remain a stubborn exception. That may soon change, says fertility expert Marcelle Cedars.
A future in which precision medicine benefits everyone is not guaranteed. For that to happen, UCSF experts argue, the health care industry must first tackle today’s health disparities, including differences in disease outcomes and access to care based on race, gender, and socioeconomic status.
With the rise of “direct-to-consumer” DNA tests, investigating your genes is easier than ever. But taking one of these tests may not be right for you, says UCSF professor Kathryn Phillips, PhD, who studies new health care technologies.
Healthy eating can be difficult to do, especially when the science isn’t clear. Our experts have weighed in to give you the best advice based on solid research, allowing you to make better choices when it comes to your nutrition.
Have you ever wondered what’s going on in a musician’s head while they improvise? In this episode, Charles Limb, MD, a UCSF surgeon and neuroscientist, explores the process of creativity by scanning the brains of jazz musicians and rappers as they improvise. Tune in to learn what brain processes allow creative thought and why creativity matters.
UCSF oncologist Pamela Munster, MD, has advised thousands of women on how to deal with the life-altering diagnosis of breast cancer. But when she got a call saying that her own mammogram showed irregularities, she found herself experiencing a whole new side of the disease. Munster’s book weaves together her personal story with her team’s research on the BRCA gene, which is responsible for breast cancer and many other inherited cancers.
The sugar industry has driven decades of biased research that shirk sugar's responsibility for chronic disease. UCSF researchers are uncovering thousands of industry documents to combat this misinformation, and steer Americans away from what is becoming a growing health crisis.
A growing number of researchers at UCSF and elsewhere have turned their attention to questions around why and how some people who age thrive and are more resilient than others.
UCSF experts share their science-backed strategies for aging well.
The ascendancy of CRISPR systems raises a grand hope: If these tools can illuminate the causes of disease in the laboratory, why not bring them into the clinic to treat patients?
Scientists began searching for ways to edit genomes in the 1960s. It would not prove easy.
As a kindergartener, Nerdette co-host Greta Johnsen was diagnosed with an eye condition that is among the best diseases for experimenting with the gene editing tool CRISPR. This episode follows Greta, her father, and UCSF geneticist and Gladstone Institutes investigator Bruce Conklin, MD, as he tries to develop the perfect CRISPR system to remove the faulty DNA from Johnsen’s eye cells.
Silicon Valley is helping researchers like Wendell Lim move basic science breakthroughs into translational applications, making treatments available to patients faster than normally possible.
The journey from discovering and developing effective, precise medications to using them correctly and safely in patients is hardly fast and easy. Nor is it a straight shot. Scientists in the UCSF School of Pharmacy are challenging the status quo every step of the way.
UCSF public health researcher Daniel Ciccarone, MD, shares his quest to understand the nation’s opioid epidemic, one user at a time.
Neuroscientist Ashley Smart shares the wonders of the brain through art.
Sugar scientist and professor of health policy Laura Schmidt, PhD, MSW, MPH, explores the tactics corporations use to get people hooked on sugary products – and how she and her colleagues are fighting back. Carry the One Radio is produced by a dedicated band of young UCSF scientists, graduate students, and postdocs.
Kristine Yaffe shares what scientists are learning about the long-term consequences of traumatic brain injury.
More than half of TBI patients are over 65 – research hasn’t caught up to the demographic shift.
Amanda Woerman explores how basic science fuels efforts to end trauma-induced brain disease.